Dr. Aline Charabaty is the Clinical Director of the GI Division and Director of the Inflammatory Bowel Diseases (IBD) Center at Johns Hopkins-Sibley Memorial Hospital. She completed her residency and GI fellowship at Georgetown University Hospital, where she joined the GI faculty and established and led the IBD center for 13 years before joining the Johns Hopkins School of Medicine faculty in January 2019. In addition to participating in traditional educational platforms, she founded @MondayNightIBD, a twitter handle that brings clinicians together to discuss the management of complex IBD cases; she received the Healio Gastroenterology Disruptive Innovator Award during ACG 2019 for this initiative, and @MondayNightIBD is cited as a reliable source of education for trainees in a ASGE statement and other peer-reviewed articles providing guidance for trainees education in the era of COVID19. This platform also aims to bring IBD patients and clinicians together, to give patients a reliable online source of information and to allow clinicians to better understand the patient experience in their approach to research and clinical care. Dr. Charabaty is the Chair of the Greater Washington DC/Virginia Crohns and Colitis Foundation (CCFn) Mission Committee since 2012, served on the CCF National Scientific Advisory Committee Patient Education and Physician Education Committees and is the recipient of the CCFn Excellence in Medicine Award in 2020. She is actively involved in educational and advocacy efforts, with CCFn, the AGA Diversity Committee and the AGA Government Affairs Committee and with the ACG second year fellows’ and regional and national courses. She is a strong advocate of women and diversity in GI and has promoted under-represented populations through her work with the AGA diversity committee, the Women in Endoscopy group and other collaborations. She was selected as a Washingtonian Top Doctors by her peers on consecutive years.

The Meyerhoff Inflammatory Bowel Disease Center is a part of The Johns Hopkins University School of Medicine, Division of Gastroenterology & Hepatology and is committed to improving the health of people with inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis.

 How to introduce Scopemanship into your training program. Bollipo S, Bilal M, Siau K and Charabaty A. In press for the Mentoring, Education and Training Corner, Gastroenterology 2020

 Pawlak KM, Kral J, Khan R, Amin S, Bilal M, Lui RN, Sandhu DS, Hashim A, Bollipo S, Charabaty A, et al. Impact of COVID-19 on endoscopy trainees: an international survey. Gastrointest Endo 2020 Jun 11;S0016-5107 (Online ahead of print) [concept, data collection and writing]

 Abu-Sbeih A, Ali F, Wang X, Mallepally N, Chen E, Altan M, Bresalier R, Charabaty A, Dadu R, Jazaeri A, Lashner B and Wang Y. Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis. J Immunother Cancer 2019; 7:93.

 Jennings J and Charabaty A. Vedolizumab induced remission in three patients with refractory microscopic colitis: A tertiary care center case series. Inflam Bowel Dis 2019 Jul 17;25(8)

 Dao A, Abidian M, Lestrange A, Mattar M, Rangnekar A and Charabaty A. Oral Vancomycin induces and maintains remission of ulcerative colitis in the subset of patients with associated primary sclerosing cholangitis. Inflam Bowel Dis ; 2019 Jun 18;25(7)

 Aby-Sbeih H, Ali S, Alsaadi D, Jennings J, Luo W, Gong Z, Richards D, Charabaty A and Wang W (co-senior authors) Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multicenter study. J Immunother Cancer 2018; 6: 142

 Malhotra N, Sahay G, Desale S, Charabaty A, Mattar M. Higher than anticipated health literacy in patients with inflammatory bowel disease: a single center experience. Gut Gastroenterol 2018 Vol 1(1); 1-5

 Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma. Gurka MK, Kim C, He AR, Charabaty A, Haddad N, Turocy J, Johnson L, Jackson P, Weiner LM, Marshall JL, Collins SP, Pishvaian MJ, Unger K. Am J Clin Oncol. 2017; 40(2):152-157

 Kaushal P, Somwaru A, Charabaty A, Levy A. MR enterography of inflammatory bowel disease with endoscopic correlation. Radiographics 2017; 37(1):116-131

 Rastogi P, Sultan M, Charabaty A, Atkins M, Mattar M. Ipilimumab associated colitis: An ipicolitis case series. World J Gastroenterol. 2015 April 14; 21(14): 4373–4378.

 Cabrera MC, Tilahun E, Nakles R, Diaz-Cruz ES , Charabaty A, Suy S, Jackson P, Ley L, Slack R, Jha R, Collins SP, Haddad N, Kallakury BV, Schroeder T, Pishvaian MJ, Furth PA.Human pancreatic cancer-associated stellate cells remain activated after in vivo chemoradiation.. Front Oncol. 2014; 4: 102, 2014

 Laiyemo A, Doubeni C., Brim H., Ashktorab H, Schoen R., Gupta S., Charabaty A., Lanza E, Smoot DT, Platz E, Cross AJ.. Short- and long-term risk of colorectal adenoma recurrence among whites and blacks. Gastrointest. Endosc. 2013; Vol 77, No: 447-454 (designated as CME activity)

 Gurka M, Collins S, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety. Rad Oncol 2013; 8: 44

 Pinsky P, Fleshman J, Mutch M, Rall C, Charabaty A, Seligson D, Dry S, Umar A, Schoen RE. One year recurrence of aberrant crypt foci. Cancer Prev Res. 2010; 3 (7): 839-43

 Mutch M., Schoen R., Fleshman J., Rall C., Dry S., Seligson D., Charabaty A., Chia D, Umar A, Viner J, Hawk E, Pinsky PF. A Multi-Center Study of Prevalence and Risk Factors for Aberrant Crypt Foci. Clin Gastroenterol Hepatol, 2009;7: 568-74

 Charabaty Pishvaian A, Collins B, Ahlawat SK, Haddad NG. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointestinal Endoscopy 2006; 64(3):412-7

 Charabaty Pishvaian A, Ahlawat S, Garvin, D and Haddad N. Role of EUS and EUS-FNA in the diagnosis of symptomatic rectosigmoid endometriosis. Gastrointestinal Endoscopy 2006; 63(2): 331-335

 Charabaty Pishvaian A, Al-Kawas F. Retroflexion in the colon: a useful and safe technique in the evaluation and resection of sessile polyps during colonoscopy. American Journal of Gastroenterology, 2006; 101:1479-83

 Ahlawat SK, Charabaty-Pishvaian A, Jackson P and Haddad N. Single-step EUS-guided pancreatic pseudocyst drainage using a large channel linear array echoendoscope and cystotome: Results in 11 patients. Journal of Pancreas 2006; 7(6): 616-24